Pubblicazioni Scientifiche

Dermatologia

15 feb 2021

Skin Barrier Function in Psoriasis and Atopic Dermatitis

Multiple diagnostic tools are used to evaluate psoriasis and atopic dermatitis (AD) severity, but most of them are based on subjective components.

09 feb 2021

COVID-19 related dermatosis in November 2019

Milan, the largest city in northern Italy, was one of the first European metropolitan areas to be affected by the COVID-19 pandemic.

09 feb 2021

Real-life experience with oral oxybutynin long-term continuous therapy

Hyperhidrosis is a disorder of excessive sweating severely impacting on patient's quality of life (Qol).

09 feb 2021

The dermoscopic inverse approach significantly

A recently introduced dermoscopic method for the diagnosis of early lentigo maligna

09 feb 2021

Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis

Psoriasis is a chronic inflammatory disease characterised by sharply demarcated erythematous and scaly skin lesions accompanied by systemic manifestations.

04 feb 2021

A multicenter study of nevus-associated melanoma versus de novo melanoma, tumor thickness and body site differences

A multicenter study of nevus-associated melanoma

04 feb 2021

The clinical spectrum of COVID-19-associated cutaneous manifestations: an Italian multicentre study

The clinical spectrum of COVID-19-associated cutaneous manifestations

04 feb 2021

Italian expert-based recommendations on the use of photo(chemo)therapy in the management of mycosis fungoides

Italian expert-based recommendations on the use of photo(chemo)therapy

26 gen 2021

Diagnosis of toenail onychomycosis by an immunochromatographic dermatophytes test strip

Diagnosis of toenail onychomycosis is based in current practice on direct microscopic examination (DME) and fungal cultures of nail samples.

26 gen 2021

Gender differences in clinical presentation, treatment, and outcomes in mycosis fungoides

Mycosis fungoides (MF) comprises 54% of cutaneous T cell lymphomas. Although the etiology is unknown, prior studies have shown that MF is more common in males than females, with greater incidence in African Americans (AAs).

26 gen 2021

Epithelioid Kaposi Sarcoma

Cutaneous Kaposi sarcoma (KS) covers a broad spectrum both clinically and pathologically. Some histological patterns of KS may be difficult to recognize and must be differentiated from other vascular neoplasms.

13 gen 2021

Hidradenitis Suppurativa and Atopic Dermatitis: A Two-Way Association

The co-existence of hidradenitis suppurativa (HS) and atopic dermatitis (AD) had been reported but was not investigated in controlled studies.

13 gen 2021

Pruritus Intensity Scales across Europe: A Prospective Validation Study

Chronic pruritus (CP) is a subjective symptom and it is necessary to assess its intensity with validated patient-reported outcome tools in order to allow determination of the treatment course

13 gen 2021

Cutaneous immune-related adverse events in patients with melanoma treated with checkpoint inhibitors

Checkpoint inhibitor (CPI) therapy has vastly improved long-term outcomes in metastatic malignant melanoma (MMM)

14 dic 2020

Androgenetic alopecia in women and men

Italian guidelines adapted from European Dermatology Forum/European Academy of Dermatology and Venereology guidelines

14 dic 2020

Immune checkpoint-mediated psoriasis

A multicentric European study of 115 patients from European Network for Cutaneous ADverse Event to Oncologic drugs (ENCADO) group

14 dic 2020

Dermatoscopy of combined blue nevi: A multicenter study of the International Dermoscopy Society

Combined blue nevi may mimic melanoma and are relatively often biopsied for diagnostic reasons.

10 dic 2020

COVID-19 and Skin Manifestations: An Overview of Case Reports/Case Series and Meta-Analysis of Prevalence Studies

Since the onset of the 2019-nCoV disease (COVID-19), many skin manifestations have been reported in COVID-19 patients

10 dic 2020

Skin barrier immunity and ageing

The skin is the outermost layer of the body with an extensive surface area of approximately 1·8 m2, and is the first line of defence against a multitude of external pathogens and environmental insults.

02 dic 2020

The 2020 International Alliance for the Control of Scabies

Consensus Criteria for the Diagnosis of Scabies